TP53 and lung adenocarcinoma: In the study by Mansuet-Lupo, mutations in 22 genes (KRAS, EGFR, BRAF, TP53, etc.)were examined in patients with multiple lung adenocarcinomas (n=120), and the results showed that mutations were detected in 91% of the patients (14).